APA (7th ed.) Citation

Q, W., W, A., S, Y., Y, X., K, L., & S, L. (2026). Integrated pan-cancer analysis and experimental validation reveal that syndecan-1 drives glioblastoma pathogenesis and associates with immune infiltration. Discover oncology, 17(1), . https://doi.org/10.1007/s12672-026-05172-0

Chicago Style (17th ed.) Citation

Q, Wang, Ai W, Yu S, Xu Y, Lei K, and Lv S. "Integrated Pan-cancer Analysis and Experimental Validation Reveal That Syndecan-1 Drives Glioblastoma Pathogenesis and Associates with Immune Infiltration." Discover Oncology 17, no. 1 (2026). https://doi.org/10.1007/s12672-026-05172-0.

MLA (9th ed.) Citation

Q, Wang, et al. "Integrated Pan-cancer Analysis and Experimental Validation Reveal That Syndecan-1 Drives Glioblastoma Pathogenesis and Associates with Immune Infiltration." Discover Oncology, vol. 17, no. 1, 2026, https://doi.org/10.1007/s12672-026-05172-0.